Important Information

      I. Value Partners Health Care Fund (the "Fund") primarily invests in equities and equity-related securities in healthcare companies on a worldwide basis.
      II. The investments of the Fund are concentrated in the health care sector which are subject to greater influences from government policies and regulations than those of other industries. The value of the Fund may be more volatile than that of a fund having a more diverse portfolio of investments.
      III. Investing in PRC market exposes the Fund to additional risks including currency repatriation risk, uncertainty of taxation policies and risk associated with Stock Connects. The Fund may also expose to RMB currency and conversion risk.
      IV. Investing in small/mid-capitalization securities may have lower liquidity and their prices are more volatile to adverse economic developments.
      V. The Fund may also invest in derivatives and debt securities that are below investment grade or unrated which can involve material risks, e.g. counterparty default risk, insolvency or liquidity risk, and may expose the Fund to significant losses.
      VI. You should not make investment decision on the basis of this marketing material alone. Please read the prospectus for details and risk factors.
     
Show all > Show less >
Capturing China's rising stars
Sectors that are best positioned for
China's paradigm shift in demographics and demand
Consistently outperforms peers in the past 5 years
and ranks in the first quartile1
across various periods

Less sensitive to
economic cycles

the fund is less volatile than China and Hong Kong equities since its inception2
Why invest in Value Partners Health Care Fund?
China catch up play

  • Aging in China is accelerating, with the over 65s reaching 170 million by 2020 and taking up 12% of the total population. By 2050, China's senior citizens will exceed that of the U.S., Japan, and Europe3
  • China lags behind the developed countries in medical spending per capita, implying immense expansion room for the medical-related sectors
China’s health expenditure per capita is only 5% of that in the U.S.

Sources: National Health Commission, IMF, OECD, statistics bureau from the respective country, medical expenditure as of 31 December 2019

Resilience and growth opportunities

  • Amid the rise of COVID-19, the healthcare sector has shown resilience. Drug sales quickly rebounded into growth territory after a decline in March
  • Healthcare companies are estimated to reach an earnings per share growth of 27% and 19% in 2020 and 2021, respectively, compared to that of the broader index
The healthcare sector is estimated to outrun the broader index in terms of EPS growth

Source: CICC, as of 28 September 2020

Relatively low volatility and correlation to the major Chinese equity index

  • The Fund's annualized return since launch is +10.6%4 , outperforming the MSCI China All Shares Health Care 10/40 Index and the CSI 300 Index with lower volatility over the same period (+9.6% and +2.5%, respectively)
The Fund has outperformed market indices since launch

For more details, please contact your bank or investment consultant. You may also contact our Fund Investor Services Team.

Hotline: +852 2143 0608
Email: hkenquiry@vp.com.hk
Other fund in focus:
Related investment insights:
Index performance is for reference only.
#Value Partners Health Care Fund is a sub-fund of Value Partners Ireland Fund ICAV (the "Company"). The Company is both authorized and supervised by the Central Bank of Ireland ("Central Bank") as an undertaking for collective investment in transferable securities pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011. Authorization of the Company by the Central Bank shall not constitute a warranty as to the performance of the Company and the Central Bank shall not be liable or the performance or default of the Company. The authorization of the Company is not an endorsement or guarantee of the Company by the Central Bank. 1. Source: Morningstar. Peer Group refers to Morningstar Category of EAA OE Sector Equity Healthcare which includes all funds with performance history started between 3 April 2015 and 30 September 2020. The Fund ranks in the first quartile over 6-month, 1-year, 3-year periods and since launch. 2. As at 30 September 2020, 3-year volatility of the Fund (Class A USD Unhedged) is 16.7% vs 26.6% of MSCI China All Shares Health Care 10/40 index and 22.2% of CSI300 index. 3. Source: Population Pyramid, Statistics Bureau of various countries, as of October 2019. 4. Value Partners Health Care Fund (“the Fund”) (Class A USD Unhedged) was launched on 2 April 2015. Calendar year return of A Units in the past five years: 2015:-3.7%; 2016: +1.9%; 2017: +20.8%; 2018 : -5.4%; 2019: +21%. 5.Volatility is a measure of the theoretical risk in terms of standard deviation, based on monthly return over the past 3 years.

The views expressed are the views of Value Partners Hong Kong Limited only and are subject to change based on market and other conditions. The information provided does not constitute investment advice and it should not be relied on as such. All materials have been obtained from sources believed to be reliable, but its accuracy is not guaranteed. This material contains certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. Investors should note investment involves risk. The price of units may go down as well as up and past performance is not indicative of future results. Investors should read the prospectus for details and risk factors.This material has not been reviewed by the Securities and Futures Commission of Hong Kong. Issuer: Value Partners Hong Kong Limited.